These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29902957)

  • 21. Improving Matching Between Recipient and Donor in Liver Transplantation: Are Scores Able to Predict Long-term Survival?
    López IP; Alonso AP; Carroll NZ; Villalba JS; Gómez EB; Jiménez AP; Herrera TV; Moral JMVD
    Transplant Proc; 2022; 54(1):41-44. PubMed ID: 34969569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
    Yun SO; Kim J; Rhu J; Choi GS; Joh JW
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
    Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
    Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
    Wronka KM; Grąt M; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Grąt K; Patkowski W; Krawczyk M
    Ann Transplant; 2017 Apr; 22():251-256. PubMed ID: 28439063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 29.  Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Xu MQ; Wang WT; Wei YG
    Ann Hepatol; 2012; 11(4):471-7. PubMed ID: 22700628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different scoring systems in predicting short-term mortality after liver transplantation.
    Elsayed FG; Sholkamy AA; Elshazli M; Elshafie M; Naguib M
    Transplant Proc; 2015 May; 47(4):1207-10. PubMed ID: 26036555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
    Dulundu E; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
    Hepatogastroenterology; 2006; 53(71):781-2. PubMed ID: 17086888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation.
    Acar Ş; Akyıldız M; Gürakar A; Tokat Y; Dayangaç M
    Turk J Gastroenterol; 2020 Nov; 31(11):782-789. PubMed ID: 33361041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of liver transplantation from old donors.
    Dudek K; Kornasiewicz O; Remiszewski P; Zieniewicz K; Wróblewski T; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2762-5. PubMed ID: 25380912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
    Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.